Literature DB >> 11074438

Defining the heating characteristics of ferromagnetic implants using calorimetry.

J A Case1, R D Tucker, J B Park.   

Abstract

The induction heating of small, cylindrical ferromagnetic implants for localized tumors is currently under investigation. These thermal rods are implanted within a lesion in 1 cm(2) arrays and subsequently exposed to an externally applied alternating magnetic field. Implants absorb energy from the field and transfer it as heat to the surrounding tissue. To achieve a uniform temperature rise throughout the tissue volume and to account for any field-rod misalignment, 400 mW of power per implant is used as the design specification. The temperature to necrose cells must be greater than 46 degrees C. A calorimeter was constructed to confirm that the rod power output specification is satisfied at temperatures adequate for inducing cell death. The rods were designed to undergo a ferromagnetic to paramagnetic transition at temperatures of 55 degrees C, 60 degrees C, 65 degrees C, and 70 degrees C; this transition produces rods that are temperature self-regulating. Calorimetric results demonstrated that 55 degrees C, 60 degrees C, 65 degrees C, and 70 degrees C rods provided 400 mW at 47-51 degrees C, 51-53.5 degrees C, 57 degrees C, and 62.5-63.5 degrees C, respectively. Thermal rods provide sufficient power output at the temperatures necessary to cause thermal ablation of tumors. The higher-temperature rods give a greater margin to ensure that necrotizing temperatures can be achieved throughout the rod array even with minor misalignment. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074438     DOI: 10.1002/1097-4636(2000)53:6<791::aid-jbm21>3.0.co;2-a

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  1 in total

1.  Calculation of heating power generated from ferromagnetic thermal seed (PdCo-PdNi-CuNi) alloys used as interstitial hyperthermia implants.

Authors:  Adly H El-Sayed; A A Aly; N I EI-Sayed; M M Mekawy; A A EI-Gendy
Journal:  J Mater Sci Mater Med       Date:  2007-03       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.